Sapir Alex 4
4 · Dova Pharmaceuticals, Inc. · Filed Aug 15, 2018
Insider Transaction Report
Form 4
Sapir Alex
DirectorPresident & CEO
Transactions
- Purchase
Common Stock
2018-08-14$22.83/sh+21,700$495,411→ 21,700 total(indirect: By Trust)
Holdings
- 46,909
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.65 - 23.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]The reportable securities are owned directly by Alexander C. Sapir Revocable Trust (the "Trust"). The Reporting person is the trustee of the Trust.